{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:12:14Z","timestamp":1793041934085,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004541","name":"Ministry of Education, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bioorg.2025.109320","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T16:27:55Z","timestamp":1764779275000},"page":"109320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Synthesis, antimicrobial activity and in-silico studies of (1-(1-arylethyl)-1H-1,2,3-triazolyl-2-phenylquinoline-4-carboxylate derivatives with click chemistry"],"prefix":"10.1016","volume":"168","author":[{"given":"Santosh","family":"Hande","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit","family":"Chavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravin C.","family":"Mhaske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.109320_bb0010","first-page":"1342","article-title":"Drug-resistance","volume":"10","author":"Mabhula","year":"2019","journal-title":"Mycobacterium tuberculosis: Where we stand, Medchemcomm"},{"key":"10.1016\/j.bioorg.2025.109320_bb0015","article-title":"Molecular epidemiology of mycobacterium tuberculosis in Ecuador: recent advances and future challenges","volume":"37","author":"Castro-Rodriguez","year":"2024","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"10.1016\/j.bioorg.2025.109320_bb0020","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/S1473-3099(18)30110-5","article-title":"Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies","volume":"18","author":"Tiberi","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bioorg.2025.109320_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.glmedi.2024.100081","article-title":"Antimicrobial resistance: impacts, challenges, and future prospects","volume":"2","author":"Ahmed","year":"2024","journal-title":"Journal of Medicine, Surgery, and Public Health"},{"key":"10.1016\/j.bioorg.2025.109320_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24655","article-title":"Antibiotic resistance: the challenges and some emerging strategies for tackling a global menace","volume":"36","author":"Chinemerem Nwobodo","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.bioorg.2025.109320_bb0035","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jiph.2022.08.004","article-title":"Development and research progress of anti-drug resistant fungal drugs","volume":"15","author":"Cui","year":"2022","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.bioorg.2025.109320_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.553648","article-title":"A 5-year review of invasive fungal infection at an Academic Medical Center","volume":"10","author":"Li","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.bioorg.2025.109320_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100885","article-title":"Dual use of antifungals in medicine and agriculture: how do we help prevent resistance developing in human pathogens?","volume":"65","author":"Verweij","year":"2022","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bioorg.2025.109320_bb0050","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41579-022-00720-1","article-title":"Tackling the emerging threat of antifungal resistance to human health","volume":"20","author":"Fisher","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bioorg.2025.109320_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsps.2012.03.002","article-title":"Quinoline: A versatile heterocyclic","volume":"21","author":"Marella","year":"2013","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.bioorg.2025.109320_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.1074331","article-title":"Recent advances in functionalized quinoline scaffolds and hybrids\u2014exceptional pharmacophore in therapeutic medicine","volume":"10","author":"Elebiju","year":"2023","journal-title":"Front. Chem."},{"key":"10.1016\/j.bioorg.2025.109320_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104639","article-title":"Quinolines, a perpetual, multipurpose scaffold in medicinal chemistry","volume":"109","author":"Yadav","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109320_bb0070","doi-asserted-by":"crossref","first-page":"20784","DOI":"10.1039\/D0RA03763J","article-title":"Recent advances in the synthesis of biologically and pharmaceutically active quinoline and its analogues: a review","volume":"10","author":"Weyesa","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2025.109320_bb0075","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ejmech.2017.09.050","article-title":"4-quinolone hybrids and their antibacterial activities","volume":"141","author":"Hu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109320_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27031003","article-title":"A review of modifications of Quinoline Antimalarials: Mefloquine and (hydroxy)chloroquine","volume":"27","author":"Kucharski","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109320_bb0085","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejmech.2017.07.061","article-title":"Quinoline hybrids and their antiplasmodial and antimalarial activities","volume":"139","author":"Hu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109320_bb0090","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.biopha.2014.10.007","article-title":"Quinoline: a promising antitubercular target","volume":"68","author":"Keri","year":"2014","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2025.109320_bb0095","doi-asserted-by":"crossref","first-page":"47096","DOI":"10.1021\/acsomega.2c06245","article-title":"Synthesis, characterization, and antimicrobial activity screening of some novel 3-(2-(3-(substituted benzyloxy)oxetan-3-yl)-3-fluorophenoxy)-8-fluoro-2-methylquinoline derivatives as potential Antimycobacterial agents","volume":"7","author":"Shinde","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2025.109320_bb0100","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1007\/s11696-023-02741-3","article-title":"Synthesis of 2-(6-substituted quinolin-4-yl)-1-alkoxypropan-2-ol as potential antimycobacterial agents","volume":"77","author":"Shinde","year":"2023","journal-title":"Chem. Pap."},{"key":"10.1016\/j.bioorg.2025.109320_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113220","article-title":"Synthetic and medicinal perspective of quinolines as antiviral agents","volume":"215","author":"Kaur","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109320_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2022.104168","article-title":"Review on recent development of quinoline for anticancer activities","volume":"15","author":"Ilakiyalakshmi","year":"2022","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.bioorg.2025.109320_bb0115","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.drudis.2012.11.003","article-title":"Quinolines: a new hope against inflammation","volume":"18","author":"Mukherjee","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2025.109320_bb0120","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1080\/17460441.2022.2129613","article-title":"The 1,2,3-triazole \u2018all-in-one\u2019 ring system in drug discovery: a good bioisostere, a good pharmacophore, a good linker, and a versatile synthetic tool","volume":"17","author":"Lengerli","year":"2022","journal-title":"Expert Opin. Drug Discovery"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109320_bb0125","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s11030-024-10858-0","article-title":"An updated review on 1, 2, 3\u2212\/1, 2, 4-triazoles: synthesis and diverse range of biological potential","volume":"29","author":"Raman","year":"2025","journal-title":"Mol. Divers."},{"key":"10.1016\/j.bioorg.2025.109320_bb0130","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7884316","article-title":"A recent overview of 1,2,3-Triazole-containing hybrids as novel antifungal agents: focusing on synthesis, mechanism of action, and structure-activity relationship (SAR)","volume":"2022","author":"Marzi","year":"2022","journal-title":"J. Chem."},{"key":"10.1016\/j.bioorg.2025.109320_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/tcr.202400107","article-title":"Comprehensive review on the synthesis of [1,2,3]Triazolo[1,5- a ]Quinolines","volume":"24","author":"Da Costa","year":"2024","journal-title":"Chem. Rec."},{"key":"10.1016\/j.bioorg.2025.109320_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2025.216675","article-title":"Recent advancements in the multifaceted biomedical efficacy of triazole based metal complexes","volume":"536","author":"Kumar","year":"2025","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.bioorg.2025.109320_bb0145","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.3762\/bjoc.17.154","article-title":"Synthesis and antimicrobial activity of 1H-1,2,3-triazole and carboxylate analogues of metronidazole","volume":"17","author":"Avula","year":"2021","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.bioorg.2025.109320_bb0150","doi-asserted-by":"crossref","DOI":"10.1186\/s13065-018-0479-1","article-title":"Design, synthesis, ADME prediction and pharmacological evaluation of novel benzimidazole-1,2,3-triazole-sulfonamide hybrids as antimicrobial and antiproliferative agents","volume":"12","author":"Al-blewi","year":"2018","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.bioorg.2025.109320_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114888","article-title":"1,2,3-Triazole-containing hybrids with potential antibacterial activity against ESKAPE pathogens","volume":"244","author":"Deng","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109320_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175710","article-title":"Effect of quinoline based 1,2,3-Triazole and its structural analogues on growth and virulence attributes of Candida albicans","volume":"12","author":"Irfan","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.bioorg.2025.109320_bb0165","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ejmech.2017.05.001","article-title":"Efficient click chemistry towards fatty acids containing 1,2,3-triazole: design and synthesis as potential antifungal drugs for Candida albicans","volume":"136","author":"Fu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109320_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29235742","article-title":"Antiviral activity of (1S,9aR)-1-[(1,2,3-Triazol-1-yl)methyl]octahydro-1H-quinolizines from the alkaloid Lupinine","volume":"29","author":"Nurmaganbetov","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109320_bb0175","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1039\/C5MD00057B","article-title":"1,2,3-Triazole derivatives as antitubercular agents: synthesis, biological evaluation and molecular docking study","volume":"6","author":"Shaikh","year":"2015","journal-title":"Medchemcomm"},{"key":"10.1016\/j.bioorg.2025.109320_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115699","article-title":"Current development of 1,2,3-triazole derived potential antimalarial scaffolds: structure- activity relationship (SAR) and bioactive compounds","volume":"259","author":"Abdul Rahman","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109320_bb0185","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1039\/D2MD00324D","article-title":"Expanding the scope of novel 1,2,3-triazole derivatives as new antiparasitic drug candidates","volume":"14","author":"Carlucci","year":"2022","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.bioorg.2025.109320_bb0190","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ejmech.2016.01.009","article-title":"The importance of triazole scaffold in the development of anticonvulsant agents","volume":"109","author":"Ayati","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109320_bb0195","doi-asserted-by":"crossref","first-page":"8797","DOI":"10.1021\/acs.jmedchem.8b00938","article-title":"Discovery of N-(4-{[5-Fluoro-7-(2-methoxyethoxy)quinazolin-4-yl]amino}phenyl)-2-[4-(propan-2-yl)-1 H-1,2,3-triazol-1-yl]acetamide (AZD3229), a potent Pan-KIT mutant inhibitor for the treatment of gastrointestinal stromal tumors","volume":"61","author":"Kettle","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109320_bb0200","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1021\/acs.jmedchem.7b00105","article-title":"1,4-substituted Triazoles as nonsteroidal anti-androgens for prostate Cancer treatment","volume":"60","author":"Ferroni","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109320_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202100158","article-title":"1,2,3-Triazole hybrids as anticancer agents: a review","volume":"355","author":"Alam","year":"2022","journal-title":"Arch Pharm (Weinheim)"},{"key":"10.1016\/j.bioorg.2025.109320_bb0210","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1021\/acs.jmedchem.6b01392","article-title":"Identification of novel Triazole-based nicotinamide Phosphoribosyltransferase (NAMPT) inhibitors endowed with Antiproliferative and Antiinflammatory activity","volume":"60","author":"Travelli","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109320_bb0215","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.bioorg.2018.10.065","article-title":"Design, synthesis and anti-Alzheimer's activity of novel 1,2,3-triazole-chromenone carboxamide derivatives","volume":"83","author":"Rastegari","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109320_bb0220","doi-asserted-by":"crossref","first-page":"24302","DOI":"10.1021\/acsomega.2c01593","article-title":"New 1,2,3-Triazole-genipin analogues and their anti-Alzheimer's activity","volume":"7","author":"Silalai","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2025.109320_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108850","article-title":"Novel functionalized 1,2,3-triazole derivatives exhibit antileishmanial activity, increase in total and mitochondrial-ROS and depolarization of mitochondrial membrane potential of Leishmania amazonensis","volume":"315","author":"Meinel","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bioorg.2025.109320_bb0230","article-title":"Chemistry of Quinoline based heterocycle scaffolds: a","volume":"7","author":"Rajni","year":"2022","journal-title":"Comprehensive Review, ChemistrySelect"},{"key":"10.1016\/j.bioorg.2025.109320_bb0235","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1002\/slct.201904455","article-title":"Synthesis and biological evaluation of new 1,2,3-Triazolyl-Pyrazolyl-Quinoline derivatives as potential antimicrobial agents","volume":"5","author":"Thakare","year":"2020","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2025.109320_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmcr.2023.100102","article-title":"Synthesis of 2-(6-substituted quinolin-4-yl)-1-(4-aryl-1H-1,2,3-triazol-1-yl) propan-2-ol as potential antifungal and antitubercular agents","volume":"7","author":"Shinde","year":"2023","journal-title":"European Journal of Medicinal Chemistry Reports"},{"key":"10.1016\/j.bioorg.2025.109320_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126671","article-title":"Synthesis and evaluation of a novel quinoline-triazole analogs for antitubercular properties via molecular hybridization approach","volume":"29","author":"Ramprasad","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.109320_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112889","article-title":"Discovery of fast-acting dual-stage antimalarial agents by profiling pyridylvinylquinoline chemical space via copper catalyzed azide-alkyne cycloadditions","volume":"209","author":"Huang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109320_bb0255","first-page":"521","article-title":"1,2,3-Triazole- and Quinoline-based hybrids with potent Antiplasmodial activity","volume":"18","author":"Graciano","year":"2022","journal-title":"Med Chem (Los Angeles)"},{"key":"10.1016\/j.bioorg.2025.109320_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107703","article-title":"Discovery of new quinoline derivatives bearing 1-aryl-1,2,3-triazole motif as influenza H1N1 virus neuraminidase inhibitors","volume":"151","author":"Sabt","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109320_bb0265","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202202783","article-title":"Synthesis, anticancer evaluation and pharmacokinetic studies of Quinoline-Triazole hybrid derivatives","volume":"7","author":"Kulu","year":"2022","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2025.109320_bb0270","series-title":"Design, Synthesis, and Evaluation of Quinoline-1,2,3-Triazole Hybrids as CYP51 Inhibitors: In Silico Study and in Vitro Antimicrobial Assessment, ChemistrySelect 9","author":"Chabhadiya","year":"2024"},{"issue":"10","key":"10.1016\/j.bioorg.2025.109320_bb0275","first-page":"678","volume":"4","author":"Mali","year":"2015","journal-title":"Original Research Article Phytochemical Screening and Antimicrobial Activity of Stevia rebaudiana Leaves"},{"key":"10.1016\/j.bioorg.2025.109320_bb0280","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1080\/07391102.2023.2217922","article-title":"Investigation of new 1,2,3-triazolyl-quinolinyl-propan-2-ol derivatives as potential antimicrobial agents: in vitro and in silico approach","volume":"42","author":"Shinde","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2025.109320_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.144240","article-title":"Current advancements and future perspectives of 1,2,3-triazoles to target lanosterol 14\u03b1-demethylase (CYP51), a cytochrome P450 enzyme: a computational approach","volume":"315","author":"Lal","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2025.109320_bb0290","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/cbdd.14266","article-title":"Recent advances in antifungal drug development targeting lanosterol 14\u03b1-demethylase (<scp>CYP51<\/scp>): a comprehensive review with structural and molecular insights","volume":"102","author":"Singh","year":"2023","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2025.109320_bb0295","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1039\/D2NJ04449H","article-title":"Synthesis, antimicrobial and ergosterol biosynthesis inhibition activity of clubbed 1,1\u2032-biphenyl-pyrazole derivatives","volume":"47","author":"Walunj","year":"2023","journal-title":"New J. Chem."},{"key":"10.1016\/j.bioorg.2025.109320_bb0300","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4236\/abc.2018.84006","article-title":"Molecular Docking Studies of <i>Alpinia galanga<\/i> Phytoconstituents for Psychostimulant Activity","volume":"08","author":"Sivanandan","year":"2018","journal-title":"Adv Biol Chem"},{"key":"10.1016\/j.bioorg.2025.109320_bb0305","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2025.109320_bb0310","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4236\/mri.2019.83003","article-title":"Thrombolytic Activity, Drug Likeness Property and ADME\/T Analysis of Isolated Phytochemicals from Ginger (<i>Zingiber officinale<\/i>) Using <i>In Silico<\/i> Approaches","volume":"08","author":"Hossain","year":"2019","journal-title":"Mod Res Inflamm"},{"key":"10.1016\/j.bioorg.2025.109320_bb0315","doi-asserted-by":"crossref","first-page":"W363","DOI":"10.1093\/nar\/gky473","article-title":"CASTp 3.0: computed atlas of surface topography of proteins","volume":"46","author":"Tian","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2025.109320_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108836","article-title":"Synthesis, human carbonic anhydrase I and II inhibition, and in silico studies of 2-ethoxy-6-formylphenyl [1,1\u2032-biphenyl]-4-sulfonate derived thiosemicarbazones","volume":"164","author":"Rafiq","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109320_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.143637","article-title":"Synthesis, biological evaluation, molecular docking and MD simulation studies of some new picolinohydrazide derivatives as cholinesterase inhibitors","volume":"1349","author":"Ku\u015ftan","year":"2026","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.109320_bb0330","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jsps.2022.04.003","article-title":"Identification of potent aldose reductase inhibitors as antidiabetic (anti-hyperglycemic) agents using QSAR based virtual screening, molecular docking, MD simulation and MMGBSA approaches","volume":"30","author":"Bakal","year":"2022","journal-title":"Saudi Pharm. J."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825012003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825012003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T09:52:53Z","timestamp":1767693173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825012003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":65,"alternative-id":["S0045206825012003"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109320","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, antimicrobial activity and in-silico studies of (1-(1-arylethyl)-1H-1,2,3-triazolyl-2-phenylquinoline-4-carboxylate derivatives with click chemistry","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109320","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109320"}}